Showing 841 - 860 results of 2,530 for search '"vaccine"', query time: 0.06s Refine Results
  1. 841
  2. 842
  3. 843
  4. 844

    Analysis of Amino Acid Changes in the Fusion Protein of Virulent Newcastle Disease Virus from Vaccinated Poultry in Nigerian Isolates by Olubukola O. Funsho-Sanni, Elijah E. Ella, Lawal D. Rogo, Olufunsho S. Sanni, Helen I. Inabo, Sodangi A. Luka, Ismaila Shittu

    Published 2022-01-01
    “…This report provides evidence of vNDV among vaccinated chicken flock and molecular information about circulating vNDV strains in Kano State, Nigeria, which is useful for the development of virus matched vaccines. …”
    Get full text
    Article
  5. 845
  6. 846

    Antigen-Specific Tissue-Resident Memory T Cells in the Respiratory System Were Generated following Intranasal Vaccination of Mice with BCG by Qiongli Wu, Shuangpeng Kang, Jun Huang, Shunqiao Wan, Binyan Yang, Changyou Wu

    Published 2021-01-01
    “…At the same time, mice were infected intranasally with live BCG and the results showed that vaccinated mice cleared up live BCG faster than nonvaccinated mice in the respiratory system. …”
    Get full text
    Article
  7. 847
  8. 848

    USE OF AN INDIRECT ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TO DETECT ANTIBODIES IN AYU (Plecogiossus altivelis) VACCINATED BY IMMERSION ADMINISTRATION by . Sukenda, Hisatsugu Wakabayashi

    Published 2007-05-01
    “…Secondly, the formalin-killed cells (FKC) of P. plecoglossicida was administered to ayu by immersion vaccination.  Two weeks after vaccination, fish were divided into two groups, one group was given booster.  …”
    Get full text
    Article
  9. 849

    Observer-Based Vaccination Strategy for a True Mass Action SEIR Epidemic Model with Potential Estimation of All the Populations by M. De la Sen, A. Ibeas, S. Alonso-Quesada

    Published 2011-01-01
    “…This paper presents a simple continuous-time linear vaccination-based control strategy for a SEIR (susceptible plus infected plus infectious plus removed populations) propagation disease model. …”
    Get full text
    Article
  10. 850
  11. 851
  12. 852
  13. 853

    Deployment and uptake of COVID-19 vaccines for refugees and migrants in regular and irregular situations: a mixed-method multicountry study by Biraj Man Karmacharya, Karl Blanchet, Jai K Das, Laetitia Nyirazinyoye, Maria Midea M Kabamalan, Nguyen Toan Tran, Zahra A Padhani, Anjali Joshi, Seyed-Moeen Hosseinalipour, Enrique Teran, Pierina Benavente, Vinay N Kampalath, Moussa Lonkila Zan, Elżbieta Anna Czapka, Cheryl Martens, Vicente B Jurlano

    Published 2025-02-01
    “…Simple vaccination registration procedures, targeted campaigns, mobile vaccination teams for hard-to-reach and vulnerable groups, and building trust in the host country authorities are pivotal for future and inclusive vaccine deployments.…”
    Get full text
    Article
  14. 854
  15. 855

    Targeted Collection of Plasmid DNA in Large and Growing Animal Muscles 6 Weeks after DNA Vaccination with and without Electroporation by Daniel Dory, Vincent Le Moigne, Roland Cariolet, Véronique Béven, André Keranflec’h, André Jestin

    Published 2015-01-01
    “…DNA vaccination has been developed in the last two decades in human and animal species as a promising alternative to conventional vaccination. …”
    Get full text
    Article
  16. 856
  17. 857
  18. 858

    FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses by Christian Simon, Ulrich J. Kudahl, Jing Sun, Lars Rønn Olsen, Guang Lan Zhang, Ellis L. Reinherz, Vladimir Brusic

    Published 2015-01-01
    “…The advanced analytical tools for vaccine discovery include visual mapping of T- and B-cell vaccine targets and assessment of neutralizing antibody coverage. …”
    Get full text
    Article
  19. 859

    Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review by Michelle Bachmann, Nejla Gültekin, Zeno Stanga, Jan S. Fehr, Ismail I. Ülgür, Patricia Schlagenhauf

    Published 2025-02-01
    “…Background: The rapid development and distribution of mRNA COVID-19 vaccines has been essential in containing the SARS-CoV-2 epidemic around the globe. …”
    Get full text
    Article
  20. 860